Rotavirusimpfung

Zusammenfassung

Die Rotavirus-Gastroenteritis gehört zu den häufigsten Erkrankungen des frühen Kin -desalters und kann zu Dehydratation, Elektro -lytentgleisung, Hospitalisation und selten zu bleibenden Schäden oder Tod führen. Normale Hygienemaßnahmen können eine Übertragung nicht sicher verhindern, sodass nosokomiale Infektionen häufig sind. In anderen europäischen und einzelnen Bundesländern haben sich 2 Lebendimpfstoffe gegen Rotaviren als effektiv und sicher erwiesen. Bei einem von 100 000 Impflingen ist mit der Möglichkeit einer zusätzlichen Invagination zu rechnen. Seit Ende August 2013 wird die Impfung auch in Deutschland für alle Säuglinge im ersten Lebenshalbjahr empfohlen.

Summary

Acute gastroenteritis due rotavirus infection is among the most frequent diseases in early childhood and may lead to dehydration, electrolyte imbalance, hospitalisation and rarely to lasting damage or death. Normal measures of hygiene cannot regularly prevent transmission and nosocomial infections occur frequently. In other European countries and a few German lands 2 live vaccines against rotavirus have been found to be effecatious and safe. Among 100,000 vaccinees 1 additional intussusception might occur. The vaccination is recommended for all German infants during the first 6 months of life since August 2013.

Schlüsselwörter

Rotavirus - Gastroenteritis - Impfung

Keywords

Rotavirus - gastroenteritis - vaccination

• Literatur

• 1 Bruijning-Verhagen P, Sankatsing V, Kunst A. et al. Rotavirus-related hospitalizations are responsible for high seasonal peaks in all-cause pediatric hospitalizations. Pediatr Infect Dis J 2012; 31: e244-e249.
• 2 Desselberger U, Huppertz HI. Immune responses to rotavirus infection and vaccination and associated correlates of protection. J Infect Dis 2011; 203: 188-195.
• 3 Forster J, Guarino A, Parez N. et al. Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis among European children younger than 5 years of age. Pediatrics 2009; 123: e393-e400.
• 4 Haber P, Patel M, Pan Y. et al. Intussusception After Rotavirus Vaccines Reported to US VAERS, 2006-2012. Pediatrics 2013; 131: 1042-1049.
• 5 Huppertz HI, Forster J, Heininger U. et al. Hammerschmidt. The parental appraisal of the morbidity of diarrhea in infants and toddlers (PAMODI) survey. Clin Pediatr 2008; 47: 363-371.
• 6 Hua W, Izurieta HS, Slade B. et al. Kawasaki disease after vaccination: reports to the vaccine adverse event reporting system 1990-2007. Pediatr Infect Dis J 2009; 28: 943-947.
• 7 Desai R, Cortese MM, Meltzer MI. et al. Potential intussusception risk versus benefits of rotavirus vaccination in the United States. Pediatr Infect Dis J 2013; 32: 1-7.
• 8 Deutsche Akademie für Kinder- und Jugendmedizin, Kommission für Infektionskrankheiten und Impfungen (2006) Empfehlungen zur Rotavirusimpfung Monatsschr Kinderheilkd 2006; 154: 1130-1132; Kinder- und Jugendarzt. 2006; 37: 401-402.
• 9 Kaiser P, Zimmer KP, Borte M, Huppertz HI. Complications in hospitalized children with acute gastroenteritis caused by rotavirus: a retrospective analysis. Eur J Pediatr 2012; 171: 337-334.
• 10 Karsten C, Baumgarte S, Friedrich AW. et al. Incidence and risk factors for community-acquired acute gastroenteritis in north-west Germany in 2004. Eur J Clin Microbiol Infect Dis 2009; 28: 935-943.
• 11 Koch J, Wiese-Posselt M. Epidemiology of rotavirus infections in children less than 5 years of age: Germany, 2001-2008. Pediatr Infect Dis J 2011; 30: 112-117.
• 12 Koch J, Mas Marques A. Epidemiologie der Rotaviruserkrankungen in Deutschland im Zeitraum von 2001-2011. Epidemiol Bulletin 5. November 2012/Nr. 44 441-449.
• 13 Paulke-Korinek M, Kundi M, Rendi-Wagner P. et al. Herd immunity after two years of universal mass vaccination program against rotavirus gastroenteritis in Austria. Vaccine 2011; 29: 2791-2796.
• 14 Shai S, Perez-Becker R, Wirsing von König CH. et al. Rotavirus disease in Germany - a prospective survey of very severe cases. Pediatr Infect Dis J 2013; 32: e62-e67.
• 15 Soriano-Gabarró M, Mrukowicz J, Vesikari T, Verstraeten T. Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J 2006; 25 (Suppl. 01) S7-S11.
• 16 Weiß S, Streng A, Kries Rv. et al. Incidence of intussusception in early infancy: a capture-recapture estimate for Germany. Klin Padiatr 2011; 223: 419-423.
• 17 Werber D, Hille K, Frank C. Years of potential life lost for six major enteric pathogens, Germany, 2004-2008. Epidemiology Infect 2013; 141: 961-968.
• 18 Clark HF, Bernstein DI, Dennehy PH. et al. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. J Pediatr 2004; 144: 184-190.
• 19 Ruuska T, Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis 1990; 22: 259-267.